49Indexed trials
mesh condition
Nervous System Diseases
Intelligence
Nervous System Diseases intelligence: 49 indexed trials, 11 recruiting studies, 49 sponsors across 43 countries.
11Recruiting
49Sponsors
43Countries
Leading sponsors
Affiris AG10 recruiting
Anova Enterprises, Inc10 recruiting
Assistance Publique - Hôpitaux de Paris10 recruiting
Beats Medical10 recruiting
Beijing Friendship Hospital10 recruiting
Danilo Toni10 recruiting
Eisai Co., Ltd.10 recruiting
Eisai Limited10 recruiting
Eli Lilly and Company11 recruiting
Elizabeth K Rhodus10 recruiting
Fondazione Don Carlo Gnocchi ETS10 recruiting
Aarhus University Hospital10 recruiting
Geographic activity
United States27trials
France8trials
Italy7trials
Canada7trials
Poland4trials
Germany4trials
China4trials
South Korea4trials
Spain4trials
Czechia4trials
Bulgaria3trials
Russia3trials
Leading interventions
E20202trials
BGG4921trials
COVID-19 swap test PCR1trials
Betashot1trials
Botulinum toxin type A1trials
Brexpiprazole, OPC-347121trials
BPN147701trials
Cedrus RB series response pad; Adtech Behnke-Fried micro-electrodes; Neuralynx or Blackrock electrophysiology system; Blackrock Cerestim or Natus Nicolet stimulator1trials
Cerebral Dopamine Neurotrophic Factor1trials
Computer decision support for physician1trials
Continuous spikes and waves during slow sleep (CSWS)1trials
Audio fairy tales1trials
Methodology note
This entity is derived from structured ClinicalTrials.gov conditions and/or MeSH normalization. Counts reflect the current NeuroRisk indexed corpus and are not guaranteed exhaustive global totals.